These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19198272)

  • 1. [Modeling of cardiovasorenal arterial hypertension in rats].
    Novgorodtseva TP; Antoniuk MV; Karaman IuK; Kotel'nikov VN; Gvozdenko TA; Korolev IB; Agofonova IG
    Patol Fiziol Eksp Ter; 2008; (4):34-6. PubMed ID: 19198272
    [No Abstract]   [Full Text] [Related]  

  • 2. [The kidney and arterial hypertension].
    Schoeppe W
    Lebensversicher Med; 1985 May; 37(3):78-9. PubMed ID: 2860547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertension 2009: what's new?].
    Burnier M; Waeber B; Pechère-Bertschi A
    Rev Med Suisse; 2009 Sep; 5(216):1747-8. PubMed ID: 19807046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional adaptation of solitary kidney].
    Bosin VIu; Deriugina LA
    Sov Med; 1990; (8):40-3. PubMed ID: 2274819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphologic characteristics of a new model of experimental kidney pathology].
    Nikitina TA; Romendik LM
    Patol Fiziol Eksp Ter; 1971; 15(3):67-9. PubMed ID: 5570505
    [No Abstract]   [Full Text] [Related]  

  • 6. Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis.
    Benter IF; Canatan H; Benboubetra M; Yousif MH; Akhtar S
    Vascul Pharmacol; 2009; 51(2-3):101-9. PubMed ID: 19410658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress.
    Tornavaca O; Pascual G; Barreiro ML; Grande MT; Carretero A; Riera M; Garcia-Arumi E; Bardaji B; González-Núñez M; Montero MA; López-Novoa JM; Meseguer A
    Circulation; 2009 Apr; 119(14):1908-17. PubMed ID: 19332469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wistar-Furth rat as a model of mineralocorticoid resistance.
    Ullian ME
    Kidney Int Suppl; 1997 Oct; 61():S10-3. PubMed ID: 9328955
    [No Abstract]   [Full Text] [Related]  

  • 9. [Structural-functional bases of kidney pathology].
    Serov VV
    Vestn Akad Med Nauk SSSR; 1970; 25(3):32-40. PubMed ID: 5430611
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arterial hypertension caused by a small cyst of the kidney].
    Komiakov BG; Guliev BG
    Urologiia; 2009; (1):66-7. PubMed ID: 19432236
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
    Khan AH; Sattar MA; Abdullah NA; Johns EJ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):501-8. PubMed ID: 19673932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bibliography. Current world literature. Renal pathophysiology.
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):467-71. PubMed ID: 16869063
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of free radicals in the progression of renal disease.
    Stratta P; Canavese C; Dogliani M; Mazzucco G; Monga G; Vercellone A
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):33-7. PubMed ID: 2024670
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
    Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
    Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
    Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Malý J; Kramer HJ; Dvorák P; Cervenka L
    Vascul Pharmacol; 2009; 51(2-3):175-81. PubMed ID: 19539780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental models of nephron reduction: some answers, many questions.
    Kleinknecht C; Terzi F; Burtin M; Laouari D; Maniar S
    Kidney Int Suppl; 1995 Jun; 49():S51-4. PubMed ID: 7674595
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of renal disease. Symposium on Pathophysiology of renal disease, Heidelberg, Aug. 30-Sept. 1, 1982.
    Contrib Nephrol; 1982; 33():1-274. PubMed ID: 7116869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glycogen splitting properties of the blood and urine in diseases of the kidneys and hypertensive disease].
    Andrenko PT
    Vrach Delo; 1966 Oct; 10():148-9. PubMed ID: 5996350
    [No Abstract]   [Full Text] [Related]  

  • 20. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension.
    Dimitriadis K; Tsioufis C; Selima M; Tsiachris D; Miliou A; Kasiakogias A; Andrikou E; Tousoulis D; Stefanadis C
    J Hum Hypertens; 2009 Oct; 23(10):668-73. PubMed ID: 19262583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.